Telemark Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Telemark Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-80,000	Closed	-$9.87M	–	52
2014 Q2	$9.87M	Sell	80,000 -20,000	-20%	-$2.21M	2.7%	14
2014 Q1	$10.4M	Hold	100,000	–	–	2.61%	15
2013 Q4	$8.99M	Buy	100,000 +20,000	+25%	+$1.6M	2.23%	14
2013 Q3	$5.35M	Buy	+80,000	New	+$5.51M	1.59%	27

Other funds holding SLXP

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Telemark Asset Management's SLXP Position: Q3 2014 in Review

Telemark Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014, closing a stake of 80,000 shares — an estimated $9.87M sold.

Telemark Asset Management first reported a position in SLXP in Q3 2013 and held it in 4 quarters. The position peaked at $10.4M in Q1 2014. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

Telemark Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q3 2014 after selling out during the quarter.
Telemark Asset Management sold 80,000 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $9.87M.
Telemark Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 4 quarters.
Telemark Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.4M in Q1 2014.
348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on Telemark Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.